It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
It is generally accepted that voltage-gated Ca2+ channels, CaV, regulate Ca2+ homeostasis in excitable cells following plasma membrane depolarization. Here, we show that the Ca2+ protein α1D of CaV1.3 channel is overexpressed in colorectal cancer biopsies compared to normal tissues. Gene silencing experiments targeting α1D reduced the migration and the basal cytosolic Ca2+ concentration of HCT116 colon cancer cell line and modified the cytosolic Ca2+ oscillations induced by the sodium/calcium exchanger NCX1/3 working in its reverse mode. Interestingly, NCX1/3 regulated membrane potential of HCT116 cells only when α1D was silenced, and blocking NCX1/3 increased cytosolic Ca2+ concentration and cell migration. However, membrane depolarization did not induce an increase in intracellular Ca2+. Patch-clamp experiments clearly showed that the inward Ca2+ current was absent. Finally, flow cytometry and immunofluorescence studies showed that α1D protein was localized at the plasma membrane, in cytosol and cell nuclei. Altogether, we uncover a novel signaling pathway showing that α1D is involved in the regulation of Ca2+ homeostasis and cell migration by a mechanism independent of its plasma membrane canonical function but that involved plasma membrane Na+/Ca2+ exchanger.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Inserm, UMR 1069, Université François Rabelais Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France
2 Inserm, UMR 1069, Université François Rabelais Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France; Department of Cellular and Molecular Physiology, Penn State University School of Medicine, Hershey Medical Center, Hershey, PA, USA
3 Equipe ERL 7368 CNRS, Université de Poitiers, Poitiers, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France
4 Inserm UMR 1078 IFR148, Université de Bretagne Occidentale, Brest, France; CHRU Brest, Brest, France
5 Inserm, UMR 1069, Université François Rabelais Tours, Tours, France; CHRU Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France
6 GICC– UMR 7292 Université de Tours, Tours, France
7 Equipe ERL 7368 CNRS, Université de Poitiers, Poitiers, France
8 GICC– UMR 7292 Université de Tours, Tours, France; CHRU Tours, Tours, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France
9 Unité d’Epidémiologie et Biostatistiques (UEB), Centre Antoine Lacassagne, Nice, France
10 Inserm UMR 1078 IFR148, Université de Bretagne Occidentale, Brest, France; Network “Ion channels and cancer-Canceropole Grand Ouest, (IC-CGO), Grand Ouest, France